InnovaRx Innova Health Strategies

D07.5

Carcinoma in situ of prostate

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 3 never code together
D07code
Excludes1
  • melanoma in situ of trunk (D03.5)D03.5
D07.5code
Excludes1
  • dysplasia (mild) (moderate) of prostate (N42.3-)N42.3-N42.3-
  • prostatic intraepithelial neoplasia II [PIN II] (N42.3-)N42.3-N42.3-

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 14
D07.5code
Inclusion terms
  • Prostatic intraepithelial neoplasia III (PIN III)
  • Severe dysplasia of prostate
D00-D09block
Includes
  • Bowen's disease
  • erythroplasia
  • grade III intraepithelial neoplasia
  • Queyrat's erythroplasia
C00-D49chapter
Notes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).C25.9
Index entries leading here 2
  • Dysplasia — see also Anomaly
  • Neoplasia
    • intraepithelial (histologically confirmed)
      • prostate (histologically confirmed) (PIN) N42.31
        • grade III (severe dysplasia) D07.5
Alongside this code 6 same parent — D07
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
D07
Block
D00-D09
Siblings
6

Present FY2024–FY2027.